{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:41:00Z","timestamp":1780454460634,"version":"3.54.1"},"reference-count":38,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Evol Bioinform Online"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has triggered a global health crisis, emphasizing the urgent need for accurate and rapid diagnostic tools. Modern molecular biology technologies, including CRISPR-Cas systems, provide highly efficient strategies for viral detection. Bioinformatic pipelines are essential for identifying conserved genomic regions and enabling rational single-guide RNA (sgRNA) design.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This study aimed to design specific sgRNAs targeting the spike gene of SARS-CoV-2 isolates from Iranian patients using the SHERLOCK diagnostic platform. Complete genomes of the RefSeq virus and 470 SARS-CoV-2 isolates, representing all variants of concern (VOCs) detected in Iran, were retrieved from the NCBI and GISAID databases. Multiple sequence alignment with ClustalW identified conserved sequences within the receptor-binding domain (RBD) that differ from the RBD of SARS-CoV and MERS-CoV RefSeq genomes. Based on these regions, sgRNAs and isothermal amplification primers were designed using ADAPT, OLIGO7, and the UCSC Genome Browser to maximize diagnostic sensitivity and specificity. Secondary and tertiary structures of sgRNA-target complexes were analyzed via RNAfold and RNAup to select the most efficient sgRNA\u2013amplicon combination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Twenty-two\u2013nucleotide sgRNA candidates were initially selected based on sequence alignment, showing high similarity to the SARS-CoV-2 RefSeq and low homology to SARS-CoV and MERS-CoV genomes. Analyses of secondary structures, RNA\u2013RNA interactions, and free energy identified 6 sgRNAs with favorable 2-dimensional conformations and strong interaction profiles. Among these, the sgRNA1\u2013Amplicon2 sequence exhibited the most stable 3-dimensional structure and a molecular docking score of \u2212309.67, indicating high sensitivity and specificity for viral detection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study successfully designed an sgRNA with high sensitivity and specificity for rapid SARS-CoV-2 detection using the CRISPR-Cas13a system, informed by genomic analysis of Iranian isolates. The proposed approach provides an efficient framework for the rapid design and deployment of CRISPR-based diagnostic tools applicable to diverse viral pathogens.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/11769343251414318","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T04:31:55Z","timestamp":1771043515000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Computational Optimization of CRISPR-Cas13a sgRNAs Targeting the SARS-CoV-2 Spike Gene for SHERLOCK-Based Diagnostics"],"prefix":"10.1177","volume":"22","author":[{"given":"Maryam","family":"Ahmadzadeh","sequence":"first","affiliation":[{"name":"Genetics Group, Department of Basic Sciences, Ale-Taha Institute of Higher Education, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4009-0827","authenticated-orcid":false,"given":"Fatemeh","family":"Akbarian","sequence":"additional","affiliation":[{"name":"Genetics Group, Department of Basic Sciences, Ale-Taha Institute of Higher Education, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Sanati","sequence":"additional","affiliation":[{"name":"Medical Genetics Department, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanieh","family":"Motaharirad","sequence":"additional","affiliation":[{"name":"Department of Embryology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, Tehran, Iran"},{"name":"Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Farrokhi","sequence":"additional","affiliation":[{"name":"Genetics Group, Department of Basic Sciences, Ale-Taha Institute of Higher Education, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28241"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2020.10.003"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14630-2"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2020.01.003"},{"issue":"4","key":"e_1_3_3_6_2","article-title":"Receptor binding and complex structures of human ACE2 to spike RBD from Omicron and Delta SARS-CoV-2","volume":"185","author":"Han P","year":"2022","unstructured":"Han P, Li L, Liu S, et al. Receptor binding and complex structures of human ACE2 to spike RBD from Omicron and Delta SARS-CoV-2. Cells. 2022;185(4):630-640.e10.","journal-title":"Cells"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2090"},{"key":"e_1_3_3_8_2","unstructured":"World Health Organization. Coronavirus disease 2019 (COVID-19): situation report 73. Published April 2 2020. Accessed August 5 2025. https:\/\/apps.who.int\/iris\/handle\/10665\/331686"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2021.113012"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.3390\/life11121356"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaq0179"},{"key":"e_1_3_3_12_2","first-page":"95","article-title":"BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT","volume":"41","author":"Hall TA","year":"1999","unstructured":"Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT. Nucleic Acids Symp Ser. 1999;41:95-98.","journal-title":"Nucleic Acids Symp Ser"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msy096"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2279-8"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/9.1.133"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/bip.360290621"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btl024"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx407"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38435-3"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar6245"},{"issue":"1","key":"e_1_3_3_21_2","article-title":"CRISPR-Cas13d effectively targets SARS-CoV-2 variants, including Delta and Omicron, and inhibits viral infection","volume":"4","author":"Liu Z","year":"2023","unstructured":"Liu Z, Gao X, Kan C, et al. CRISPR-Cas13d effectively targets SARS-CoV-2 variants, including Delta and Omicron, and inhibits viral infection. MedComm (2020). 2023;4(1):e208.","journal-title":"MedComm (2020)"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/1748-7188-6-26"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkl243"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx279"},{"key":"e_1_3_3_25_2","article-title":"Thermodynamically optimized CRISPR-Cas13a assays for high-efficiency viral RNA detection in resource-limited settings","volume":"15","author":"Karimi M","year":"2025","unstructured":"Karimi M. Thermodynamically optimized CRISPR-Cas13a assays for high-efficiency viral RNA detection in resource-limited settings. Sci Rep. 2025;15:11405.","journal-title":"Sci Rep"},{"key":"e_1_3_3_26_2","article-title":"Impact of SARS-CoV-2 mutations on qPCR detection efficiency: analysis of N1-probe variants in clinical and wastewater samples","volume":"14","author":"Endo N","year":"2024","unstructured":"Endo N, Kitajima M, Hata A, et al. Impact of SARS-CoV-2 mutations on qPCR detection efficiency: analysis of N1-probe variants in clinical and wastewater samples. Sci Rep. 2024;14:62659.","journal-title":"Sci Rep"},{"key":"e_1_3_3_27_2","first-page":"83","article-title":"Cross-contamination risks in molecular diagnostic laboratories: challenges and preventive strategies in low-resource settings","volume":"71","author":"Pakzad R","year":"2020","unstructured":"Pakzad R, Safi S, Ahmadi E, et al. Cross-contamination risks in molecular diagnostic laboratories: challenges and preventive strategies in low-resource settings. Pol J Pathol. 2020;71:83-90.","journal-title":"Pol J Pathol"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2017.22.13.30494"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04266-9"},{"issue":"7","key":"e_1_3_3_30_2","first-page":"3095","article-title":"Evolutionary analysis of the Delta and Omicron SARS-CoV-2 variants highlights their high transmissibility and reduced sensitivity to neutralization","volume":"94","author":"Kannan SR","year":"2022","unstructured":"Kannan SR, Spratt AN, Cohen AR, et al. Evolutionary analysis of the Delta and Omicron SARS-CoV-2 variants highlights their high transmissibility and reduced sensitivity to neutralization. J Med Virol. 2022;94(7):3095-3106.","journal-title":"J Med Virol"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijheh.2023.114224"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf5573"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature24049"},{"key":"e_1_3_3_34_2","first-page":"20","article-title":"Massively parallel Cas13 screens reveal principles for guide RNA design","volume":"188","author":"Wessels HH","year":"2021","unstructured":"Wessels HH, M\u00e9ndez-Mancilla A, Guo X, et al. Massively parallel Cas13 screens reveal principles for guide RNA design. Methods. 2021;188:20-30.","journal-title":"Methods"},{"issue":"12","key":"e_1_3_3_35_2","article-title":"Massively parallel Cas13 screens reveal principles for guide RNA design","volume":"48","author":"Wessels HH","year":"2020","unstructured":"Wessels HH, M\u00e9ndez-Mancilla A, Guo X, et al. Massively parallel Cas13 screens reveal principles for guide RNA design. Nucleic Acids Res. 2020;48(12):e69.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1060947"},{"key":"e_1_3_3_37_2","article-title":"Molecular epidemiology and mutation analysis of SARS-CoV-2 in Iran: implications for diagnostics","volume":"252","author":"Khoshkam Z","year":"2023","unstructured":"Khoshkam Z, Rezaei S, Shokouhi S, et al. Molecular epidemiology and mutation analysis of SARS-CoV-2 in Iran: implications for diagnostics. Int J Hyg Environ Health. 2023;252:114224.","journal-title":"Int J Hyg Environ Health"},{"key":"e_1_3_3_38_2","article-title":"In silico design and evaluation of CRISPR-based diagnostics for emerging viral pathogens","volume":"134","author":"Khan S","year":"2021","unstructured":"Khan S, Jain S, Singh R, et al. In silico design and evaluation of CRISPR-based diagnostics for emerging viral pathogens. Comput Biol Med. 2021;134:104538.","journal-title":"Comput Biol Med"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-019-0210-2"}],"container-title":["Evolutionary Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11769343251414318","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/11769343251414318","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11769343251414318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:56:36Z","timestamp":1777409796000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/11769343251414318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":38,"alternative-id":["10.1177\/11769343251414318"],"URL":"https:\/\/doi.org\/10.1177\/11769343251414318","relation":{},"ISSN":["1176-9343","1176-9343"],"issn-type":[{"value":"1176-9343","type":"print"},{"value":"1176-9343","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"article-number":"11769343251414318"}}